Antiphospholipid (Hughes') syndrome (APS) has not been reported in African-Americans (A-A) as frequently as in other ethnic groups. We describe eight A-A female patients with APS, including two cases of primary APS (PAPS), four with APS secondary to systemic lupus erythematosus (SLE), one with Sjögren's syndrome, and one with overlap connective tissue disease (CTD). Their mean age was 34 y (range 24–47 y). Patients were followed for a mean of 6 y (range 0.3–11 y). During follow up, both anticardiolipin (aCL) and anti-b2glycoprotein-I (ab2GPI) antibodies were measured in stored sera by enzyme-linked immunosorbent assay (ELISA). IgA was the most frequent isotype of aCL and ab2GPI, and co-occurred with the IgM isotype in three of four patients with neurologic manifestations.
Harris EN , Baguley E , Asherson RA et al. Clinical and serological features of the `antiphospholipid syndrome' . Br J Rheumatol1987; 26: (Suppl 2) S19-S19 .
2.
Piette J-C . 1996 diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a `mission impossible'?Lupus1996; 5: 354—363 .
3.
Asherson RA , Khamashta MA , Ordi-Ros J et al. The “primary” antiphospholipid syndrome: major clinical and serological features . Medicine1989; 68: 366—374 .
4.
Symmons DPM . Occasional Series: lupus around the world, frequency of lupus in people of African origin . Lupus1995; 4: 176—178 .
5.
McCarty DJ , Manzi S , Medsger TA et al. Incidence of systemic lupus erythematosus, race and gender differences . Arthritis Rheum1995; 38: 1260—1270 .
6.
Wilson WA , Perez MC , Michalski JP , Armatis PE . Cardiolipin antibodies and null alleles of C4 in black Americans with systemic lupus erythematosus . J Rheumatol1988; 15: 1768—1772 .
7.
Molina JF , Gutierrez-Urena S , Molina J et al. Variability of anticardiolipin antibody isotype distribution in 3 geographic populations of patients with systemic lupus erythematosus . J Rheumatol1997; 24: 291—296 .
8.
Cucurull E , Mendez E , Diri E et al. Prevalence, isotype distribution and clinical significance of anticardiolipin and anti-b2glycoprotein-I anti-bodies in African-American patients with SLE . Lupus1998; 7: 22-22 (abstract).
9.
Perez MC , Wilson WA , Brown HL , Scopelitis E . Anticardiolipin antibodies in unselected pregnant women: relationship to fetal outcome . J Perinatol1991; 11: 33—36 .
10.
Harris EN , Gharavi E , Patel SP , Hughes GRV . Evaluation of the anti-cardiolipin antibody test: Report of an international workshop held 4 April 1986 . Clin Exp Immunol1987; 68: 215—222 .
11.
Gharavi E , Lockshin MD . Antiphospholipid antibodies. In: Rose NR , de Macario EC , Folds JD , Lane HC , Nakamura RM (eds) Manual of Clinical Laboratory Immunology. ASM: Washington DC , 1997 pp 949—953.
12.
Roubey RAS , Eisenberg RA , Harper MF , Winfield JB . `Anticardiolipin' autoantibodies recognize b2-glycoprotein I in the absence of phospholipid, importance of Ag density and bivalent binding . J Immunol1995; 154: 954—960 .
13.
Cucurull E , Espinoza LR , Mendez E et al. Anticardiolipin and anti-b2glycoprotein I antibodies in patients with systemic lupus erythematosus: Comparison between Colombians and Spaniards . Lupus1999; 8: 134—141 .
14.
Rosler DH , Conway MD , Anaya JM et al. Ischemic optic neuropathy and high level anti-cardiolipin antibodies in primary Sjögren's syndrome . Lupus1995; 4: 155—157 .
15.
Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: Report of an international workshop. Arthritis Rheum1999; In press.
16.
Sammaritano LR , Ng S , Sobel R et al. Anticardiolipin IgG subclasses, association of IgG2 with arterial and/or venous thrombosis . Arthritis Rheum1997; 40: 1998—2006 .
17.
McNally T , Mackie IJ , Machin SJ et al. Increased levels of b2glycoprotein-I antigen and b2 glycoprotein-I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphospholipid syndrome . Br J Rheumatol1995; 34: 1031—1036 .
18.
Gharavi AE , Harris EN , Asherson RA et al. Anticardiolipin antibodies: isotype distribution and phospholipid specificity . Ann Rheum Dis1987; 46: 1—6 .
19.
Wilson WA , Faghiri Z , Taheri F et al. Significance of IgA antiphospholipid antibodies . Lupus1998; 7: S110—113 .
20.
Kalunian KC , Peter JB , Middlekauff HR et al. Clinical significance of a single test for anti-cardiolipin antibodies in patients with systemic lupus erythematosus . Am J Med1988; 85: 602– 608 .
21.
Escalante A , Brey RL , Mitchell BD et al. Accuracy of anticardiolipin antibodies in identifying a history of thrombosis among patients with systemic lupus erythematosus . Am J Med1995; 98: 559—565 .
22.
Lopez LR , Santos ME , Espinoza LR et al. Clinical significance of immunoglobulin A versus immunoglobulins G and M anti-cardiolipin antibodies in patients with systemic lupus erythematosus, correlation with thrombosis, thrombocytopenia, and recurrent abortion . Am J Clin pathol1992; 98: 449—454 .
23.
Weidmann CE , Wallace DJ , Peter JB et al. Studies of IgG, IgM and IgA antiphospholipid antibody isotypes in systemic lupus erythematosus . J Rheumatol1988; 15: 74—79 .
24.
Merkel PA , Chang Y , Pierangeli SS et al. The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases . Am J Med1996; 101: 576—583 .
25.
Tsutsumi A , Matsuura E , Ichikawa K et al. IgA Class anti-b2 – glycoprotein I in patients with systemic lupus erythematosus . J Rheumatol1998; 25: 74—78 .
26.
Fanopoulos D , Teodorescu MR , Varga J et al. High Frequency of abnormal levels of IgA anti-b2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome . J Rheumatol1998; 25: 675—680 .
27.
Pierangeli SS , Liu XW , Barker JH et al. Induction of thrombosis in a mouse model by IgG, IgM and IgA immunoglobulins from patients with the antiphospholipid syndrome . Thromb Haemost1995; 74: 1361– 1367 .
28.
Cabiedes J , Cabral AR , Alarcon-Segovia D . Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-b2-glycoprotein-I than with antiphospholipid antibodies . J Rheumatol1995; 22: 1899—1906 .
29.
Day MH , Thiagarajan P , Ahn C et al. Autoantibodies to b2-glycoprotein I in systemic lupus erythematosus and primary anti-phospholipid antibody syndrome: clinical correlations in comparison with other antiphospholipid antibody tests . J Rheumatol1998; 25: 667– 674 .
30.
Wilson WA , Morgan OSC , Barton EN et al. IgA antiphospholipid antibodies in HTLV-1-associated tropical spastic paraparesis . Lupus1995; 4: 138—141 .
31.
Frampton G , Winer JB , Cameron JS et al. Severe Guillain-Barre syndrome: an association with IgA anti-cardiolipin antibody in a series of 92 patients . J Neuroimmunol1988; 19: 133—139 .
32.
Abernethy ML , McGuinn JL , Callen JP . Widespread cutaneous necrosis as the initial manifestation of the antiphospholipid antibody syndrome . J Rheumatol1995; 22: 1380—1383 .
33.
Hojnik M , George J , Ziporen L et al. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome . Circulation1996; 93: 1579—1587 .
34.
Vianna JL , Khamashta MA , Ordi-Ros J et al. Comparison of the primary and secondary antiphos-pholipid syndrome: a European multicenter study of 114 patients . Am J Med1994; 96: 3—9 .
35.
Galve E , Ordi J , Barquinero J et al. Valvular heart disease in the primary antiphospholipid syndrome . Ann Intern Med1992; 116: 293—298 .
